Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening

In this era of precision medicine, there is an increasingly urgent need for highly sensitive tests for detecting tumors such as colon cancer (CC), a silent disease where the first symptoms may take 10–15 years to appear. Mass spectrometry-based lipidomics is an emerging tool for such clinical diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Anna Maria A.P., Messias, Marcia C.F., Duarte, Gustavo H.B., de Santis, Gabrielle K.D., Mecatti, Giovana C., Porcari, Andreia M., Murgu, Michael, Simionato, Ana Valéria C., Rocha, Thalita, Martinez, Carlos A.R., Carvalho, Patricia O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345851/
https://www.ncbi.nlm.nih.gov/pubmed/32630389
http://dx.doi.org/10.3390/metabo10060262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345851/
https://www.ncbi.nlm.nih.gov/pubmed/32630389
http://dx.doi.org/10.3390/metabo10060262

Ejemplares similares